PCLOF (PharmaCielo) Total Stockholders Equity: $-11.13 Mil (As of Dec. 2025)


What is PharmaCielo Total Stockholders Equity?

PharmaCielo PCLOF +17.45% Total Stockholders Equity is $-11.13 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

PharmaCielo's Total Stockholders Equity for the quarter that ended in Dec. 2025 was $-11.13 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PharmaCielo's Book Value per Share for the quarter that ended in Dec. 2025 was $-0.06. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PharmaCielo's Debt-to-Equity for the quarter that ended in Dec. 2025 was -1.21.

PharmaCielo  (OTCPK:PCLOF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PharmaCielo's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-11.131-0)/187.984
=-0.06

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PharmaCielo's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(13.517 + 0) / -11.131
=-1.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCielo Total Stockholders Equity Related Terms

PharmaCielo Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for PharmaCielo's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCielo Total Stockholders Equity Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial 34.52 20.49 15.10 4.71 -1.25

PharmaCielo Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.61 -5.28 -8.07 -10.80 -11.13
What does a Total Stockholders Equity of $-11.13 Mil mean?
PharmaCielo (PCLOF) has a Total Stockholders Equity of $-11.13 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for PharmaCielo and its competitors.
Is PharmaCielo's Total Stockholders Equity too high?
PharmaCielo's current Total Stockholders Equity is $-11.13 Mil.
How does PharmaCielo's Total Stockholders Equity compare to ZTS and UTHR?
PharmaCielo's Total Stockholders Equity of $-11.13 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for PharmaCielo and its competitors. PharmaCielo's current Total Stockholders Equity is $-11.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCielo stock overvalued right now?
Based on GuruFocus' analysis, PharmaCielo (PCLOF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.09, compared to a current price of $0.04 — trading 50% below its estimated fair value. The current Total Stockholders Equity is $-11.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For PharmaCielo (PCLOF), the current Total Stockholders Equity is $-11.13 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCielo Business Description

Other Exchanges PCLO:Canada
Address 82 Richmond Street East, Suite 805, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico and generates the majority of its revenue in the form of the Sale of Cannabis derivative products in America followed by Australia, Africa and Europe.